US 10420773
Methods of treating developmental disorders and/or seizure disorders with etifoxine
granted A61KA61K31/536A61P
Quick answer
US patent 10420773 (Methods of treating developmental disorders and/or seizure disorders with etifoxine) held by OVID THERAPEUTICS INC. expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/536, A61P, A61P25/00, A61P25/22